Biofil Chemicals & Pharmaceuticals Ltd Share Price

Trading - Medium / SmallNSE
₹29.37
-0.89-2.94% (1D)
As on 20 Nov 2026 at 15:50
As of 20 Nov 2026 at 15:50, Biofil Chemicals & Pharmaceuticals Ltd is trading at ₹29.37. The 52-week range stands at ₹25.60–₹46.34, with a market cap of ₹49.98 crore. At a P/E of 96.00 and a dividend yield of 0.00%, it is a small-cap stock in the Pharmaceuticals sector.

BIOFILCHEM Price Chart

Market Cap
₹49.98 Cr
PE Ratio
96.00
ROCE
3.65%

Biofil Chemicals & Pharmaceuticals Ltd Performance

Biofil Chemicals & Pharmaceuticals Ltd Fundamentals

Know More
Market Cap₹49.98 Cr
ROE2.37%
P/E Ratio (TTM)96.00
EPS (TTM)₹0.32
P/B Ratio2.29
Dividend Yield0.00%
Industry P/E91.72
Book Value₹13.39
Debt to Equity0.10
Face Value₹10

Biofil Chemicals & Pharmaceuticals Ltd Shareholding Pattern

Know More
Promoter46.8%
Foreign Institutions0%
Mutual Funds0%
Domestic Institutions0.1%
Public53.1%

Biofil Chemicals & Pharmaceuticals Ltd Financial Statements

Know More
No data for this view.

Biofil Chemicals & Pharmaceuticals Ltd Peer Comparison

Know More
StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Sun Pharmaceutical Industries Ltd
₹1,885.10
-14.90(-0.78%)
4,52,298.61,583.7 - 2,046.9
Torrent Pharmaceuticals Ltd
₹4,698.80
87.80(+1.90%)
1,78,727.33,672.3 - 5,250.0
Dr Reddys Laboratories Ltd
₹1,390.50
-10.40(-0.74%)
1,16,144.51,101.0 - 1,414.9
Cipla Ltd
₹1,414.95
-3.55(-0.25%)
1,14,312.11,165.7 - 1,539.7
Lupin Ltd
₹2,010.00
11.20(+0.56%)
91,915.91,892.9 - 2,529.5

About Biofil Chemicals & Pharmaceuticals

Biofil Chemicals & Pharmaceuticals Limited (BCPL) was incorporated as a Private Limited Company on 4 January, 1985 for manufacturing and trading of Pharmaceuticals products. Later on, the Company was converted into a Public Limited Company on 7 May, 1992. The Company deals in providing job work facility in respect of manufacturing of pharmaceuticals drug. It runs the business via two unit viz Pharmaceutical Division & Chemicals Division. In Feb.'96, the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively, both aggregating Rs 23.21 cr, to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations. The company currently manufactures pharmaceutical formulations like injections, capsules, eye-drops and dry syrups at its plant located in Indore. BCPL's new unit was set up at Pithampur in Madhya Pradesh at a project costing Rs 39.75 cr. The Company entered into business partnership with HLL Lifecare Limited (Formerly Hindustan Latex Ltd) an undertaking of Government of India. As per the agreed terms it provided manufacturing facility to HLL Lifecare Limited for manufacturing of Iron and Folic Acid Tablets (IFA) and other Pharmaceuticals products as required by HLL. Presently, the Company is flourishing business activates at Pithampur, in Madhya Pradesh. The Company is not only dealing in the pharmaceutical product but has diversified its business activity in producing plastic products required for packing of pharmaceutical product and other plastic products. During the year 2025-26, the Company has obtained the approval of its shareholders through a Postal Ballot by passing special resolution on 13th September, 2025 for the sale, transfer, or other disposal of the leasehold rights of the industrial land in Dhar district of Madhya Pradesh.

Parent Organisation—
Founded1985
Managing DirectorKetan Shah
NSE SymbolBIOFILCHEM

Biofil Chemicals & Pharmaceuticals Ltd Resistance and Support levels

R330.93R230.61R130.41S129.77S229.57S329.2529.37

Biofil Chemicals & Pharmaceuticals Ltd Technicals

Current Price
₹29.37 ₹0.89 (-2.94%)
Bearish
12
Bullish
0
  • 20 Day3.3%
  • 50 Day4.5%
  • 100 Day6.9%
  • 200 Day11.8%

Biofil Chemicals & Pharmaceuticals Ltd Latest News

View More
03 NOV 2026 | Tuesday
Biofil Chemicals to convene board meeting November 14 to review financial results
06 OCT 2026 | Tuesday
Biofil Chemicals confirms securities dematerialization via Ankit Consultancy, per BSE filing
24 SEPT 2026 | Thursday
Biofil Chemicals shareholders approved Ashok Ramawat’s directorship extension until September 2027
24 SEPT 2026 | Thursday
Biofil Chemicals halts trading for insiders ahead of quarterly results release
11 AUG 2026 | Tuesday
Biofil Chemicals extends directorship of Ashok Kumar Ramawat pending shareholder approval
01 AUG 2026 | Saturday
Biofil Chemicals to review quarterly financial results at August 11 board meeting
22 MAY 2026 | Friday
Biofil Chemicals & Pharmaceuticals to discuss results

2026

Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial

Frequently asked questions

The share price of Biofil Chemicals & Pharmaceuticals Ltd is ₹29.37 as of 20 Nov 2026 at 15:50.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now